Latest University of Colorado Denver Stories
A decade after the 9/11 attacks, significant parts of America's most prominent downtowns remain largely sealed off as `security zones,' but a newly published study by University of Colorado Denver professor Jeremy NÃ©meth says this has led to blighted landscapes, limited public access and a need for a new approach to urban planning.
Fresh water and reusable energy. Humans are on a constant hunt for a sustainable supply of both.
DENVER, Colo., Nov. 23, 2010 /PRNewswire/ -- Omni Bio Pharmaceutical, Inc. (OTC Bulletin Board: OMBP), today announced that U.S.
AURORA, Colo., Sept. 27 /PRNewswire/ -- The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has completed the selection process from its first solicitation announced in February. The announcement is made by Richard C.
For decades scientists believed Neanderthals developed 'modern' tools and ornaments solely through contact with Homo sapiens, but new research from the University of Colorado Denver now shows these sturdy ancients could adapt, innovate and evolve technology on their own.
DENVER, May 19 /PRNewswire/ -- Flanked by more than 100 leaders from business, healthcare and city and state government, Corporex officials broke ground on Fitzsimons Village, an $80 million hotel office complex in the Fitzsimons Life Sciences District in Aurora, Colo. Fitzsimons Village is the first new, mixed-use development that will bring needed amenities to the rapidly growing Fitzsimons Life Sciences District east of Denver.
IOS Press announces publication of a special issue of NeuroRehabilitation: An International Journal (NRE) devoted specifically to hypoxic-ischemic brain injury (HI-BI), a significant disruption of brain function due to a deficient supply of oxygen to the brain.
AURORA, Colo., March 18 /PRNewswire/ -- Pharmatech Oncology has been selected by the Fitzsimons Redevelopment Authority to be a preferred vendor to the Colorado Science + Technology Park at Fitzsimons. The Technology Park is home to 25 pharmaceutical and biotechnology companies.